Israel’s Biond Biologics (see here previously) has begun multi-center trials of BND-35. It is already trialing BND-22. Both are immunotherapy treatments for solid tumors. https://nocamels.com/2024/06/novel-cancer-immunotherapy-drug-given-to-first-patient-in-trial/ https://www.biondbio.com/clinical-trials/ https://www.clinicaltrials.gov/study/NCT06274437?term=BND-35&rank=1 https://www.clinicaltrials.gov/study/NCT04717375?term=BND-22&rank=1

Israel’s Biond Biologics (reported here previously) has signed an exclusive worldwide license agreement with Sanofi for its innovative cancer therapies. Biond will receive $125 million up-front with more than $1 billion in potential payments. Biond’s plans BND-22 human trials to … Continue reading →

I’ve reported previously (see here) on Israeli medical innovations to boost the immune system to fight diseases. Israeli biotech Biond Biologics is developing a platform to enable antibodies to enter cells, destroy tumors or treat autoimmune diseases. Biond just raised … Continue reading →